Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)
Close on Nov 18, 2026Market cap $3.04BP/E –Yield –
Telix Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Telix Pharmaceuticals's cash was $251.91M at Jun 30, 2026. For fiscal 2025 it was $141.87M, down 67.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.87M | -67.8% |
| FY2024 | Dec 31, 2024 | $440.00M | +422.0% |
| FY2023 | Dec 31, 2023 | $84.30M | +7.0% |
| FY2022 | Dec 31, 2022 | $78.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $251.91M | +198.8% |
| Q4 FY2025 | Dec 31, 2025 | $141.87M | +80.1% |
| Q2 FY2025 | Jun 30, 2025 | $207.16M | – |
| Q4 FY2024 | Dec 31, 2024 | $440.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $84.30M | – |
| Q4 FY2022 | Dec 31, 2022 | $78.78M | – |
See a number that looks wrong?